deaths from tirzepatide Clinical Outcomes of or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes SUMMIT: Tirzepatide a 'Huge Win'

The study confirmed that lixisenatide exerts a more pronounced effect on postprandial glycemic variations with a modest effect on fasting glucose levels

(1992) The toxicity of selenium in experimental freshwater ponds, Arch

Cruise ship travel with GLP-1 medications Cruises present a unique combination of challenges

Role of glucagon-like peptide-1 (GLP-1) receptor agonists in cardiovascular risk management in patients with type 2 diabetes mellitus: A systematic review

GGCT affects the proliferation by disrupting the redox balance in tumor cells To explore the biological function of GGCT, we analyzed transcriptome data by knocking down GGCT in MHCC97H cells (GSE282603) and compared it with the published data from PC3 cells (GSE154584)